BTC / USD
22,686.43
2.24%
(-520.15)
ETH / USD
1,631.32
2.53%
(-42.37)
XRP / USD
0.39
1.85%
(-0.01)
LTC / USD
96.55
4.46%
(-4.51)
EOS / USD
1.07
2.99%
(-0.03)
BCH / USD
130.24
3.5%
(-4.72)
ADA / USD
0.39
2.36%
(-0.01)
XLM / USD
0.09
2.19%
(-0)
NEO / USD
9.24
1.26%
(+0.12)
XEM / USD
0.04
4.67%
(-0)
DASH / USD
62.99
3.74%
(-2.45)
USDT / USD
1.00
0%
(0)
BNB / USD
322.76
2.37%
(-7.84)
QTUM / USD
2.98
0.88%
(+0.03)
XVG / USD
0.00
2.68%
(-0)
ONT / USD
0.23
4.43%
(-0.01)
ZEC / USD
44.28
4.59%
(-2.13)
STEEM / USD
0.22
4.08%
(-0.01)

Awakend – Scam Review Part 3

0

Vietal Nutrition, a Zenith formulator, has given Awakend with a written statement detailing the supplement’s origins.

The move follows Awakend’s failure to be upfront regarding the origins of the Zenith addition, which has resulted in continued doubt.

After noticing Awakend releasing a doctored research report, BehindMLM sensed something was wrong with Zenith.

The research was released in 2008, fourteen years before Zenith was founded. To get around this, Awakend added “Zenith” into the research without explanation, prompting us to report on the study’s doctoring.

This forced Zenith to insert a disclaimer stating that the study only applied to “the supplement.”

The original brand name of the supplement, now known as Zenith, has been removed from this page.

The “original brand name” was Trisynex, which was widely accessible for a much lower price than Awakend had set for Zenith. Because of this, there is some doubt about Awakend’s retail viability as an MLM prospect.

The FTC has consistently stated that MLM organizations that do not have significant retail sales are pyramid schemes.

Zenith formulator has given a statement from its attorneys in what looks to be an effort to put the subject to rest.

The above remark has been included as a preface to the 2008 Trisynex research, which is available on Awakend’s website.

According to my understanding, Trisynex was initially sold as Max WLX by Max International.

Max International and Imagenetix created their own Trisynex clone formula sometime in the late 2000s, which looks to have been a flop (people were ill, the supplement did not function, etc.).

To summarize, Max International is still in business, but Max WLX and Imagenetix are no more. In 2012, TriPharma sued Imagenetix into bankruptcy.

TriPharma claims to have created the first Trisynex supplement.

Trisynex… has been used by TriPharma LLC since 2007 in the promotion and selling of TriPharma’s weight reduction medication.

TriPharma has since changed its name to Vietal Nutrition.

Roger Catarino (right) and his businesses, First Fruits Business Ministry and First Fruits Beverages Company, come to mind.

According to TriPharma, Catarino and his First Fruits enterprises “sought to purchase, infringe on, and even adulterate” Trisynex.

A Pacer search for Catarino’s First Fruit companies yields no fewer than 40 court dockets, several of which are related to TriPharma.

TriPharma claims to have obtained Vietal Nutrition.

a 2013 injunction and approximately $4.5 million fraud judgment against infringing parties Roger Catarino personally, as well as his entities First Fruits Business Ministry LLC and the now-defunct First Fruits Beverage Company LLC

TriPharma LLC has fought in California courts to defend those rights against baseless claims and fraudulent activities by Mr. Catraino and the First Fruits infringers, including seeking to enforce the 2013 Judgment, which has grown to over $7 million with interest and is still unpaid by Mr. Catarino and the First Fruits infringers.

Vietal Nutrition, now known as TriPharma, let the Trisynex trademark expire in 2018. Catarino and First Fruits took advantage of this.

In 2018 … Infringers My Catarino and First Fruits applied to register the trademark Trisynex in an attempt to steal the tradename and create ambiguity where none existed.

TriPharma promptly filed a challenge to the First Fruits petition, which is now ongoing before the USPTO Trademark Trial and Appeal Board

To be fair to Vietal Nutrition, it appears that the Trisynex trademark dispute is now unsettled.

Catarino and First Fruits are marketing and selling Trisynex right now, while Awakend launches its MLM opportunity with Zenith.

And they’re using the same patents and data that Vieteal Nutrition uses to advertise its Zenith version.

Shelly Jo Hypno Aminos’ “TrimFit with Trisynex” is, in my opinion, the most notable example of First Fruits’ Trisynex.

TrimFit costs $39.99 for 120 pills (a serving size is 2 capsules). On autoship, Awakend’s Zenith costs $135 per month.

TrimFit can also be purchased straight from Catarino at TrimFit for Life.

The asking price is $39.95, which is significantly less than Zenith’s $135 monthly fee.

Vietal Nutrition continues to exist.

The ownership of TriPharma over the (Trisynex) clinical trials, as well as the original product and formula used to create the original medication, cannot be questioned.

Again, not to diminish Vietal Nutrition, but that doesn’t mean much when Catarino and First Fruits have been publicly marketing Trisynex for years.

Who owns the Trisynex patent as of September 20, 2022?

Trisynex is covered by United States Patent No. 6,899,892.

Trisynex, one of the initial tradenames used to advertise the innovative weight reduction product based on US Patent No. 6,899,892 entitled “Methods to Reduce Body Fat,” has been used by TriPharma LLC in the marketing and sale of TriPharma’s weight loss product since 2007.

I attempted to seek up this number on the USPTO website and soon gave up (absolute website design fail).

Fortunately, Google Patents has a copy of the patent. United States Patent No. 6,899,892 is tagged “expired-lifetime” as of March 19th, 2022.

Looking up the meaning of this status reveals

An expired patent no longer provides any protection to the inventor or patent owner.

When a patent expires, the concept becomes freely available for use, redesign, and marketing by any organization or individual without the consent of the original patent owner.

United States Patent No. 6,899,892 was last assigned to First Fruits Business Ministry in July 2011 before it expired. There is a lot of litigation in California, but no change of assignee.

Another point that Vietal Nutrition does not answer is whether or not First Fruits’ Trisynex formulation is similar to their own.

TrimFit’s nutritional label and marketing claims strongly imply that it is:

When I last checked in at Awakend, they hadn’t yet made Zenith’s product label available.

Since then, they’ve put a “view label” button on their website…

…but it accomplishes nothing at the time of posting.

Finally, as if all of this wasn’t confusing enough, Awakend’s 2008 research only applies to Imagentix’s version of Trisynex. Which they ceased selling ten years ago?

Imagenetix commissioned the study, which begs the issue of why TriPharma did not conduct their own. Remember how they sued Imagenetix into oblivion over Trisynex?

I did not make this mess. I’m not sure how to remedy this issue, but I have some ideas.

Zenith’s introduction, in my opinion, was premature. Simply put, you can’t compete with what looks to be an identical product being sold for nearly half the price.

I don’t think the patent issue is as simple as Vietal Nutrition makes it out to be; otherwise, why is Catarino’s Trisynex still available after all these years?

He’s the one that sold Trisynex till Zenith, not Vietal Nutrition. And why is an Imagentix-commissioned research being pushed around when they’ve been sued by both Vietal Nutrition and First Fruits?

Catarino and Vietal Nutrition have had fourteen years, surely enough time to do their own research?

Taking a step back and examining Awakend as an MLM enterprise, Zenith has not yet been delivered out. According to Awakend’s website, Zenith will be available “fall 2022.”

If the situation with Catarino and First Fruits isn’t handled by Fall 2022, Zenith will be bankrupt. No retail consumer in their right mind would pay $135 per month for Zenith when TrimFit only $39.95.

As a result, Awakend distributors are selling Zenith to Awakend distributors, which the FTC considers to be a pyramid scheme. Then there’s the NFT nonsense on top of that – luckily, it’s a distinct problem in terms of Zenith.

Given that Vietal Nutrition’s comment spans a full page, I was expecting it would finally clarify what is going on with Trisynex. It doesn’t, and now we have an MLM firm based on “exclusive rights” that don’t appear to be exclusive at all.

More significantly, how can you provide exclusive rights to a product for which you do not possess the patent?

Unless I’m mistaken, US Patent No. 6,899,892 is no longer valid and may be used by anybody.

Given that Awakend and Zenith appeared a few months after US Patent No. 6,899,892 expired, is all that is occurring is that Awakend is being created on the assumption that anybody may now make Trisynex?

If that’s the case, what’s with Vietal Nutrition’s exclusive bullshit and posturing?

TriPharma will continue to protect its rights and cleanse the market of fraudsters and infringers who have attempted to postpone the product’s availability for public usage and benefit.

Any other party, including Mr. Catarino and the First Fruits infringers, who markets a product based on the UCONN clinical study owned by Vietal Nutrition and licensed to Awakened is infringing on Vietal/intellectual Awakend’s property rights and will be removed from the market to avoid confusion and harm to the public.

What am I doing wrong?

To summarize, if anyone can produce Trisynex and Awakend and hope to sell the same formula for $135 per month over $39.95 per bottle, Zenith is doomed.

When sales from pyramid recruiting cease, all that remains are expensive Awakend “founder” cartoon NFTs.

I’m not anticipating any, but if there are any new developments, I’ll post them below.

9th September 2022 – Update First Fruits Business Ministry has issued a cease and desist letter to Awakend regarding its Zenith marketing claims.

TriPharma (dba Vietal Nutrition) has secured the appointment of a Receiver as of September 14, 2022.

FFBM will be placed under the control of the Receiver. The funds generated will be used to pay TriPharma’s 2013 judgment against FFBM.

Awakend has also removed the previously provided Trisynex study from their website, unless I’m mistaken.

Leave A Reply

Your email address will not be published.